Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis.

Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A.

Clin Infect Dis. 2013 May;56(9):1261-8. doi: 10.1093/cid/cit052.

2.

Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.

Pericas JM, Cervera C, del Rio A, Moreno A, Garcia de la Maria C, Almela M, Falces C, Ninot S, Castañeda X, Armero Y, Soy D, Gatell JM, Marco F, Mestres CA, Miro JM; Hospital Clinic Endocarditis Study Group..

Clin Microbiol Infect. 2014 Dec;20(12):O1075-83. doi: 10.1111/1469-0691.12756.

4.

Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.

Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A.

Ann Intern Med. 2007 Apr 17;146(8):574-9.

PMID:
17438316
5.

Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.

Miro JM, Cervera C, Garcia-de-la-Maria C, Del Rio A, Armero Y, Mestres CA, Grau JM, Marco F, Moreno A.

Scand J Infect Dis. 2008;40(11-12):968-72. doi: 10.1080/00365540802398945.

PMID:
18767002
7.

Editorial Commentary: Enterococcus faecalis infective endocarditis: is it time to abandon aminoglycosides?

Munita JM, Arias CA, Murray BE.

Clin Infect Dis. 2013 May;56(9):1269-72. doi: 10.1093/cid/cit050. No abstract available.

8.

Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.

Gavaldá J, Onrubia PL, Gómez MT, Gomis X, Ramírez JL, Len O, Rodríguez D, Crespo M, Ruíz I, Pahissa A.

J Antimicrob Chemother. 2003 Sep;52(3):514-7.

9.

Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis.

Euba G, Lora-Tamayo J, Murillo O, Pedrero S, Cabo J, Verdaguer R, Ariza J.

Antimicrob Agents Chemother. 2009 Oct;53(10):4305-10. doi: 10.1128/AAC.00444-09.

10.

In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis: high in vitro synergistic effect of the association ceftriaxone-fosfomycin.

Farina C, Russello G, Chinello P, Pasticci MB, Raglio A, Ravasio V, Rizzi M, Scarparo C, Vailati F, Suter F; Italian Infective Endocarditis Study Group (SEI)..

Chemotherapy. 2011;57(5):426-33. doi: 10.1159/000330458.

PMID:
22122863
11.

Enterococcus faecalis infective endocarditis: a pilot study of the relationship between duration of gentamicin treatment and outcome.

Dahl A, Rasmussen RV, Bundgaard H, Hassager C, Bruun LE, Lauridsen TK, Moser C, Sogaard P, Arpi M, Bruun NE.

Circulation. 2013 Apr 30;127(17):1810-7. doi: 10.1161/CIRCULATIONAHA.112.001170.

12.

Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.

Gavaldà J, Torres C, Tenorio C, López P, Zaragoza M, Capdevila JA, Almirante B, Ruiz F, Borrell N, Gomis X, Pigrau C, Baquero F, Pahissa A.

Antimicrob Agents Chemother. 1999 Mar;43(3):639-46.

13.

[Enterococcal endocarditis: a multicenter study of 76 cases].

Martínez-Marcos FJ, Lomas-Cabezas JM, Hidalgo-Tenorio C, de la Torre-Lima J, Plata-Ciézar A, Reguera-Iglesias JM, Ruiz-Morales J, Márquez-Solero M, Gálvez-Acebal J, de Alarcón-González A; Grupo para el Estudio de las Infecciones Cardiovasculares de la Sociedad Andaluza de Enfermedades Infecciosas..

Enferm Infecc Microbiol Clin. 2009 Dec;27(10):571-9. doi: 10.1016/j.eimc.2009.02.007. Spanish.

PMID:
19477041
14.
15.

Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.

Gavaldà J, Cardona PJ, Almirante B, Capdevila JA, Laguarda M, Pou L, Crespo E, Pigrau C, Pahissa A.

Antimicrob Agents Chemother. 1996 Jan;40(1):173-8.

16.

Once-daily aminoglycoside in the treatment of Enterococcus faecalis endocarditis: case report and review.

Tam VH, Mckinnon PS, Levine DP, Brandel SM, Rybak MJ.

Pharmacotherapy. 2000 Sep;20(9):1116-9.

PMID:
10999505
17.

Combination therapy for enterococcal endocarditis.

Gelfand MS, Cleveland KO.

Clin Infect Dis. 2013 Sep;57(5):767. doi: 10.1093/cid/cit338. No abstract available.

18.

Enterococcal endocarditis revisited.

Pericás JM, Zboromyrska Y, Cervera C, Castañeda X, Almela M, Garcia-de-la-Maria C, Mestres C, Falces C, Quintana E, Ninot S, Llopis J, Marco F, Moreno A, Miró JM.

Future Microbiol. 2015;10(7):1215-40. doi: 10.2217/fmb.15.46. Review.

PMID:
26118390
19.
Items per page

Supplemental Content

Support Center